首页> 美国卫生研究院文献>other >Rapid 16S rRNA Next-Generation Sequencing of Polymicrobial Clinical Samples for Diagnosis of Complex Bacterial Infections
【2h】

Rapid 16S rRNA Next-Generation Sequencing of Polymicrobial Clinical Samples for Diagnosis of Complex Bacterial Infections

机译:快速16S rRNA下一代测序的微生物临床样品的复杂细菌感染的诊断

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Classifying individual bacterial species comprising complex, polymicrobial patient specimens remains a challenge for culture-based and molecular microbiology techniques in common clinical use. We therefore adapted practices from metagenomics research to rapidly catalog the bacterial composition of clinical specimens directly from patients, without need for prior culture. We have combined a semiconductor deep sequencing protocol that produces reads spanning 16S ribosomal RNA gene variable regions 1 and 2 (∼360 bp) with a de-noising pipeline that significantly improves the fraction of error-free sequences. The resulting sequences can be used to perform accurate genus- or species-level taxonomic assignment. We explore the microbial composition of challenging, heterogeneous clinical specimens by deep sequencing, culture-based strain typing, and Sanger sequencing of bulk PCR product. We report that deep sequencing can catalog bacterial species in mixed specimens from which usable data cannot be obtained by conventional clinical methods. Deep sequencing a collection of sputum samples from cystic fibrosis (CF) patients reveals well-described CF pathogens in specimens where they were not detected by standard clinical culture methods, especially for low-prevalence or fastidious bacteria. We also found that sputa submitted for CF diagnostic workup can be divided into a limited number of groups based on the phylogenetic composition of the airway microbiota, suggesting that metagenomic profiling may prove useful as a clinical diagnostic strategy in the future. The described method is sufficiently rapid (theoretically compatible with same-day turnaround times) and inexpensive for routine clinical use.
机译:对包括复杂的,多菌种患者标本的单个细菌种类进行分类,对于常规临床应用中的基于培养物的和分子微生物学技术仍然是一个挑战。因此,我们采用了宏基因组学研究的方法,可以快速对直接来自患者的临床标本的细菌成分进行分类,而无需事先培养。我们结合了一种半导体深度测序方案,该方案可产生跨越16S核糖体RNA基因可变区1和2(〜360 bp)的读段,并带有消噪管线,可显着提高无错误序列的比例。所得序列可用于执行准确的属或种级分类学分配。我们通过深度测序,基于培养物的菌株分型和批量PCR产品的Sanger测序探索具有挑战性的异质临床标本的微生物组成。我们报道深度测序可以对混合标本中的细菌种类进行分类,而常规临床方法无法从中获得可用数据。对来自囊性纤维化(CF)患者的痰液样本进行深度测序后,发现标本中描述良好的CF病原体无法通过标准的临床培养方法检测到,尤其是对于低流行或难治细菌。我们还发现,根据气道微生物群的系统发育组成,可以将提交CF诊断检查的痰液分为有限的几类,这表明宏基因组分析可能会在将来作为临床诊断策略有用。所描述的方法足够快(理论上与当天的周转时间兼容)并且对于常规临床使用而言便宜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号